Is PCELL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PCELL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate PCELL's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate PCELL's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PCELL?
Key metric: As PCELL is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for PCELL. This is calculated by dividing PCELL's market cap by their current
revenue.
What is PCELL's PS Ratio?
PS Ratio
5.6x
Sales
SEK 317.72m
Market Cap
SEK 1.79b
PCELL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: PCELL is expensive based on its Price-To-Sales Ratio (5.6x) compared to the Swedish Electrical industry average (1.4x).
Price to Sales Ratio vs Fair Ratio
What is PCELL's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
PCELL PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
5.6x
Fair PS Ratio
1.3x
Price-To-Sales vs Fair Ratio: PCELL is expensive based on its Price-To-Sales Ratio (5.6x) compared to the estimated Fair Price-To-Sales Ratio (1.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst PCELL forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
SEK 34.42
SEK 42.75
+24.2%
15.4%
SEK 53.00
SEK 35.00
n/a
4
Nov ’25
SEK 42.90
SEK 43.00
+0.2%
14.6%
SEK 53.00
SEK 36.00
n/a
4
Oct ’25
SEK 38.58
SEK 42.00
+8.9%
15.5%
SEK 53.00
SEK 36.00
n/a
4
Sep ’25
SEK 23.82
SEK 38.33
+60.9%
4.4%
SEK 40.00
SEK 36.00
n/a
3
Aug ’25
SEK 25.40
SEK 38.33
+50.9%
4.4%
SEK 40.00
SEK 36.00
n/a
3
Jul ’25
SEK 30.40
SEK 40.67
+33.8%
9.1%
SEK 45.00
SEK 36.00
n/a
3
Jun ’25
SEK 40.30
SEK 40.67
+0.9%
9.1%
SEK 45.00
SEK 36.00
n/a
3
May ’25
SEK 27.34
SEK 40.67
+48.7%
9.1%
SEK 45.00
SEK 36.00
n/a
3
Apr ’25
SEK 29.70
SEK 49.00
+65.0%
26.5%
SEK 62.00
SEK 36.00
n/a
2
Mar ’25
SEK 35.01
SEK 49.00
+40.0%
26.5%
SEK 62.00
SEK 36.00
n/a
2
Feb ’25
SEK 41.39
SEK 175.00
+322.8%
22.9%
SEK 215.00
SEK 135.00
n/a
2
Jan ’25
SEK 46.27
SEK 175.00
+278.2%
22.9%
SEK 215.00
SEK 135.00
n/a
2
Dec ’24
SEK 42.46
SEK 175.00
+312.2%
22.9%
SEK 215.00
SEK 135.00
n/a
2
Nov ’24
SEK 43.36
SEK 161.75
+273.0%
23.7%
SEK 215.00
SEK 117.00
SEK 42.90
4
Oct ’24
SEK 53.58
SEK 151.40
+182.6%
26.5%
SEK 215.00
SEK 110.00
SEK 38.58
5
Sep ’24
SEK 69.10
SEK 151.40
+119.1%
26.5%
SEK 215.00
SEK 110.00
SEK 23.82
5
Aug ’24
SEK 96.06
SEK 151.40
+57.6%
26.5%
SEK 215.00
SEK 110.00
SEK 25.40
5
Jul ’24
SEK 83.94
SEK 151.40
+80.4%
26.5%
SEK 215.00
SEK 110.00
SEK 30.40
5
Jun ’24
SEK 78.96
SEK 151.40
+91.7%
26.5%
SEK 215.00
SEK 110.00
SEK 40.30
5
May ’24
SEK 86.76
SEK 163.40
+88.3%
21.1%
SEK 215.00
SEK 117.00
SEK 27.34
5
Apr ’24
SEK 117.45
SEK 167.00
+42.2%
18.0%
SEK 215.00
SEK 135.00
SEK 29.70
5
Mar ’24
SEK 136.80
SEK 167.00
+22.1%
18.0%
SEK 215.00
SEK 135.00
SEK 35.01
5
Feb ’24
SEK 141.00
SEK 158.75
+12.6%
20.8%
SEK 215.00
SEK 135.00
SEK 41.39
4
Jan ’24
SEK 119.05
SEK 158.75
+33.3%
20.8%
SEK 215.00
SEK 135.00
SEK 46.27
4
Dec ’23
SEK 129.30
SEK 158.75
+22.8%
20.8%
SEK 215.00
SEK 135.00
SEK 42.46
4
Nov ’23
SEK 124.40
SEK 158.75
+27.6%
20.8%
SEK 215.00
SEK 135.00
SEK 43.36
4
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.